Yunnan Baiyao Group Overview

  • Year Founded
  • 1902

Year Founded

  • Status
  • Public

  • Employees
  • 9,286

Employees

  • Stock Symbol
  • 000538

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $8.46
  • (As of Friday Closing)

Yunnan Baiyao Group General Information

Description

Yunnan Baiyao Group Co Ltd is engaged in the manufacturing and marketing of medicines, which include herbal products, daily health products, raw medicine, drug classics, and others.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • No. 3686, Yunnan Baiyao Street
  • Chenggong District
  • Kunming, Yunnan 650500
  • China
+86 0871
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Personal Products
Stock Exchange
SHE
Vertical(s)
Corporate Office
  • No. 3686, Yunnan Baiyao Street
  • Chenggong District
  • Kunming, Yunnan 650500
  • China
+86 0871

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Yunnan Baiyao Group Stock Performance

As of 20-Nov-2026, Yunnan Baiyao Group’s stock price is $8.46. Its current market cap is $15.1B with 1.78B shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$8.46 $8.43 $6.81 - $8.49 $15.1B 1.78B 9.1M $0.42

Yunnan Baiyao Group Financials Summary

As of 30-Sep-2026, Yunnan Baiyao Group has a trailing 12-month revenue of $6.21B.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 11,348,526 12,657,206 12,637,970 10,783,078
Revenue 6,208,004 5,727,321 5,579,196 5,528,192
EBITDA 867,750 880,931 813,632 691,398
Net Income 754,237 716,626 661,897 578,636
Total Assets 8,183,489 7,756,311 7,248,419 7,587,435
Total Debt 50,172 69,693 96,516 281,648
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Yunnan Baiyao Group Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Yunnan Baiyao Group‘s full profile, request access.

Request a free trial

Yunnan Baiyao Group Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Yunnan Baiyao Group Co Ltd is engaged in the manufacturing and marketing of medicines, which include herbal products, da
Other Pharmaceuticals and Biotechnology
Kunming, China
9,286 As of 2025

Zhangzhou, China
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Yunnan Baiyao Group Competitors (1)

One of Yunnan Baiyao Group’s competitors is Zhangzhou Pien Tze Huang Pharmaceutical, a Corporation company based in Zhangzhou, China.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Zhangzhou Pien Tze Huang Pharmaceutical Corporation Zhangzhou, China
You’re viewing 1 of 1 competitors. Get the full list »

Yunnan Baiyao Group Patents

Yunnan Baiyao Group Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026228387-A1 Anti-lrrc15 antibody and use thereof Pending 27-Apr-2025
WO-2026228386-A1 Anti-nectin-4 antibody and use thereof Pending 27-Apr-2025
AU-2022437929-A1 Antibody molecule against growth and differentiation factor 15 and use thereof Active 26-Jan-2022
AU-2022437929-B2 Antibody molecule against growth and differentiation factor 15 and use thereof Active 26-Jan-2022
EP-4471059-A1 Antibody molecule against growth and differentiation factor 15 and use thereof Pending 26-Jan-2022 C07K16/22
To view Yunnan Baiyao Group’s complete patent history, request access »

Yunnan Baiyao Group Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Yunnan Baiyao Group Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Yunnan Baiyao Group‘s full profile, request access.

Request a free trial

Yunnan Baiyao Group Investments & Acquisitions (2)

Yunnan Baiyao Group’s most recent deal was a Merger/Acquisition with Juyaotang Pharmaceutical for . The deal was made on 11-Oct-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Juyaotang Pharmaceutical 11-Oct-2025 Merger/Acquisition Pharmaceuticals
Joint Venture (Yunnan Baiyao Group/ Ban Loong Holdings) 23-Apr-2021 Joint Venture Other Pharmaceuticals and Biotechnology
To view Yunnan Baiyao Group’s complete investments and acquisitions history, request access »

Yunnan Baiyao Group ESG

Risk Overview

Risk Rating

Updated November, 17, 2026

34.22 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,593

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Pharmaceuticals

Subindustry

of 354

Rank

Percentile

To view Yunnan Baiyao Group’s complete esg history, request access »

Yunnan Baiyao Group Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Juyaotang Pharmaceutical Anguo, China 2013

Yunnan Baiyao Group FAQs

  • When was Yunnan Baiyao Group founded?

    Yunnan Baiyao Group was founded in 1902.

  • Where is Yunnan Baiyao Group headquartered?

    Yunnan Baiyao Group is headquartered in Kunming, China.

  • What is the size of Yunnan Baiyao Group?

    Yunnan Baiyao Group has 9,286 total employees.

  • What industry is Yunnan Baiyao Group in?

    Yunnan Baiyao Group’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Yunnan Baiyao Group a private or public company?

    Yunnan Baiyao Group is a Public company.

  • What is Yunnan Baiyao Group’s stock symbol?

    The ticker symbol for Yunnan Baiyao Group is 000538.

  • What is the current stock price of Yunnan Baiyao Group?

    As of 20-Nov-2026 the stock price of Yunnan Baiyao Group is $8.46.

  • What is the current market cap of Yunnan Baiyao Group?

    The current market capitalization of Yunnan Baiyao Group is $15.1B.

  • What is Yunnan Baiyao Group’s current revenue?

    The trailing twelve month revenue for Yunnan Baiyao Group is $6.21B.

  • Who are Yunnan Baiyao Group’s competitors?

    Zhangzhou Pien Tze Huang Pharmaceutical is a competitor of Yunnan Baiyao Group.

  • What is Yunnan Baiyao Group’s annual earnings per share (EPS)?

    Yunnan Baiyao Group’s EPS for 12 months was $0.42.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process